Enantiomerically pure phosphoindoles as HIV inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 16, 2013
Grant Date -
Oct 20, 2011
app pub date -
Jun 2, 2011
filing date -
Sep 29, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
3-phosphoindole compounds substantially in the form of a single enantiomer useful for the treatment of Flaviviridae virus infections, and particularly for HIV infections are provided. Also provided are pharmaceutical compositions comprising the 3-phosphoindole compounds alone or in combination with one or more other anti-viral agents, processes for their preparation, and methods of manufacturing a medicament incorporating these compounds.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully